Lexapro

This page shows the latest Lexapro news and features for those working in and with pharma, biotech and healthcare.

Lundbeck and Otsuka start phase III for Rexulti in bipolar

protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).

Lundbeck and Otsuka's Rexulti set for August launch in US

which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
NICE backs drug to cut alcohol consumption

its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
Lundbeck still feeling effects from Cipralex patent loss

The antidepressant sales dropped another 33% in the third quarter
NICE recommends Lundbeck’s alcohol dependency drug

Lundbeck has high hopes for Selincro as it tries to overcome the impact of the loss of patent protection for its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
Lundbeck launches Brintellix in first EU market

The first EU launch of Brintellix is another important step for the Danish company as it recovers from the loss of patent protection for its antidepressant Lexapro (escitalopram oxalate), a former ... Clinical trial results suggest Brintellix is at least

More from news
Approximately 2 fully matching, plus 30 partially matching documents found.

Pharma deals during February 2014

s best selling depression drug Lexapro and another patent cliff looming for Nameda, its Alzheimer's drug in 2015.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Improve clinical trials through patient journey mapping: Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...